The group led by Joost Martens is studying abnormal proteins called oncofusion proteins and their role in cancer development. Understanding the binding regions, the effects on gene activity, and the associated epigenetic features can provide valuable information about the underlying mechanisms of cancer and potentially lead to the development of targeted therapies or diagnostic tools. The group is part of RIMLS-Science.
Molecular Haematology
Research group
Contact information
Interested in our research or would you like to join our group? Please get in touch with Vesna Andonov.